Norwegian CDMO Curida, which offers a wide range of analytical, development, and manufacturing services for OINDPs, has announced a new strategic partnership with pharmAccel Consulting Director René Bommer. In July 2015, Curida acquired a nasal spray manufacturing facility in Elverum, Norway from Takeda, and the company cites Bommer's expertise in nasal spray … [Read more...] about Curida announces alliance with OINDP consultant René Bommer
People
Kent Kresa takes over as MannKind’s Chairman of the Board
MannKind Corporation has announced the resignation of Alfred Mann as Executive Chairman and the appointment of Kent Kresa as Chairman of the Board, effective immediately. Mann will continue as a non-executive advisor, the company said. Kresa is Chairman Emeritus of Northrop Grumman Corporation and has served on the boards of numerous companies, universities, and … [Read more...] about Kent Kresa takes over as MannKind’s Chairman of the Board
Discovery Labs appoints Craig Fraser as President and CEO, provides update on Aerosurf program
Discovery Laboratories, which recently released positive Phase 2a data for its Aerosurf aerosolized KL4 surfactant and advanced the product into Phase 2b, has announced the appointment of Craig Fraser as President and CEO. Fraser was most recently Chief Operating Officer of Aegerion Pharmaceuticals and previously held positions at Pfizer, Wyeth, and Johnson & Johnson. … [Read more...] about Discovery Labs appoints Craig Fraser as President and CEO, provides update on Aerosurf program
Liquidia Technologies appoints new VP, Business Development & Strategy
Particle engineering specialist Liquidia Technologies announced that it has hired Jason Adair as VP, Business Development & Strategy. Adair was most recently Executive Director of Corporate Development at BioCryst and was previously Director of Business Development at MedImmune. Liquidia CEO Neal Fowler commented, "Jason brings extensive business development and … [Read more...] about Liquidia Technologies appoints new VP, Business Development & Strategy
MannKind appoints Matthew J. Pfeffer as CEO
MannKind Corporation has appointed Matthew J. Pfeffer as CEO effective January 10, 2016, replacing Alfred Mann. In November 2015, Mann temporarily resumed his role as CEO after Hakan Edstrom stepped down. On January 5, 2016, MannKind announced that Sanofi would return the rights to its Afrezza inhaled insulin and that it was considering options for the product. … [Read more...] about MannKind appoints Matthew J. Pfeffer as CEO
Turing Pharmaceuticals names Ron Tilles interim CEO
After the arrest of its CEO, Martin Shkreli, on securities fraud charges, Turing Pharmaceuticals has announced Shkreli's resignation and the appointment of Ron Tilles as Interim CEO. Tilles has chaired Turing's board of directors since the company's inception. Turing launched in 2014 after Shkreli's former employer Retrophin ousted him over alleged stock trading … [Read more...] about Turing Pharmaceuticals names Ron Tilles interim CEO
Pharmaterials announces promotions, new hire
UK-based CDMO Pharmaterials Ltd has announced the promotions of Chris Landeg to VP, Operations and Martin Wing-King to Director, Business Development and Project Management. The company also said that it has hired Yogesh Davé as Senior Director of QA. Landeg joined Pharmaterials in 2007 as Director of Business Development; Wing-King joined the company in 2008 as … [Read more...] about Pharmaterials announces promotions, new hire
Mark Iwicki appointed Pulmatrix board chairman
Dry powder inhalation products developer Pulmatrix has appointed former Civitas Therapeutics CEO Mark Iwicki as chairman of its board of directors, the company said. Iwicki has also previously headed Blend Pharmaceuticals and Sunovion and currently sits on the boards of directors of Kala Pharmaceuticals, Aimmune, Nimbus Therapeutics, Merus and Taris … [Read more...] about Mark Iwicki appointed Pulmatrix board chairman
Hakan Edstrom steps down as CEO of MannKind Corporation
MannKind Corporation has announced the resignation of Hakan Edstrom, who was the company's President and CEO, as well as a director. In the wake of the resignation, Alfred Mann has been appointed interim CEO, effective November 19, 2015, and a board committee has begun a search for a new CEO. Edstrom took over as CEO from Mann in January 2015, prior to Sanofi's … [Read more...] about Hakan Edstrom steps down as CEO of MannKind Corporation
Insys Therapeutics announces management changes
Insys Therapeutics has announced the resignation of President and CEO Michael L. Babich and the appointment of John N. Kapoor to those positions, effective November 4, 2015. The company also named Daniel Brennan as Executive VP and COO. The effective date of the CEO change is the same day that CNBC aired an investigative report about Insys, which is under … [Read more...] about Insys Therapeutics announces management changes